447 filings
EFFECT
BFFTF
Biofrontera AG
14 Mar 22
Notice of effectiveness
12:15am
6-K
BFFTF
Biofrontera AG
9 Mar 22
Biofrontera files Form 15F to suspend SEC Reporting Requirements and starts trading Level I ADS program on US OTC market
5:53pm
15F-12B
BFFTF
Biofrontera AG
9 Mar 22
Securities registration termination (foreign)
4:27pm
POS AM
BFFTF
Biofrontera AG
9 Mar 22
Prospectus update (post-effective amendment)
2:35pm
S-8 POS
BFFTF
Biofrontera AG
9 Mar 22
Registration of securities for employees (post-effective amendment)
2:29pm
SC 13D/A
xy0h 6316639uf
25 Feb 22
Biofrontera / DEUTSCHE BALATON AKTIENGESELLSCHAFT ownership change
4:01pm
25
438ocqgkj 7wijp2ql
24 Feb 22
Voluntary exchange delisting
4:05pm
6-K
ykzf51t
24 Feb 22
Current report (foreign)
2:13pm
6-K
ry9ph 6dte
22 Feb 22
Current report (foreign)
10:00am
6-K
tepxaqwp8xh oh2w
14 Feb 22
Current report (foreign)
12:00am
SC 13G
mny0n7jobta2t17o6d4
10 Feb 22
Biofrontera / Biofrontera ownership change
4:05pm
6-K
qhtfl3yhe5
1 Feb 22
Current report (foreign)
10:00am
6-K
fnf purbsqh
13 Jan 22
Biofrontera announces preliminary revenue figures for the full year 2021
9:26am
6-K
g9xpdzim 50q
29 Dec 21
Current report (foreign)
6:20am
SC 13D/A
wzhmoj0ooxxw1okr6b
21 Dec 21
Biofrontera / DEUTSCHE BALATON AKTIENGESELLSCHAFT ownership change
4:01pm
6-K
cevar
14 Dec 21
Annual General Meeting
2:24pm
6-K
4u4lhv2rwtqrw8v
13 Dec 21
Current report (foreign)
10:22am
6-K
r5sa8 88xp
8 Dec 21
Biofrontera AG obtains notice of allowance for US patent on PDT-lamp and treatment method
8:43am
6-K
vi5jmhauv
2 Dec 21
Biofrontera obtains notice of allowance for US patent on innovative illumination protocol
10:01am
6-K
we1x123p3f4203 3b9
2 Dec 21
Biofrontera AG announces timing of the departure of the CEO
7:37am